Twist Bioscience Corporation TWST Americas — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's americas — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's americas — revenue?
- Twist Bioscience Corporation (TWST) reported americas — revenue of $64.31M in Q1 2026.
- How has Twist Bioscience Corporation's americas — revenue changed year-over-year?
- Twist Bioscience Corporation's americas — revenue increased by 16.5% year-over-year, from $55.19M to $64.31M.
- What is the long-term trend for Twist Bioscience Corporation's americas — revenue?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's americas — revenue has grown at a 30.4% compound annual growth rate (CAGR), from $77.91M to $225.58M.
- What does americas — revenue mean?
- This metric represents the total gross revenue generated from sales of synthetic biology products and services within the Americas geographic region. It serves as a key indicator of the company's market penetration and commercial success in its primary domestic and regional markets. Tracking this figure helps investors assess regional demand trends and the effectiveness of local sales and distribution strategies.